BMO Capital lowered the firm’s price target on Livent to $20 from $24 and keeps a Market Perform rating on the shares. The analyst cites the company’s Q3 earnings miss and reduced guidance primarily due to continued delays to the Argentine carbonate expansion and amid lower lithium prices and lower lithium multiples.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on LTHM:
- Livent price target lowered to $29 from $32 at KeyBanc
- Livent Releases Third Quarter 2023 Results
- Livent lowers FY23 revenue view to $890M-$940M from $1.025B-$1.125B
- Livent reports Q3 adjusted EPS 44c, consensus 46c
- Livent options imply 6.1% move in share price post-earnings
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue